Remove Allergies Remove Cardiology Remove Doctors Remove Medicine
article thumbnail

Disrupted medical conferences: Lessons learnt

pharmaphorum

The shift to virtual alone has already had a profound impact on all conference stakeholders: medical societies themselves, doctors, patients, commercial partners, and professional conference organisers (PCOs). Doctors want a choice. These order of magnitude increases were also reflected at national levels. yes; and 15.7%

Doctors 105
article thumbnail

Velocity Expands to 17 Sites in Europe

Velocity Clinical Research

Dr. Kirsten said, “Since the beginning of our career as internal medicine doctors and pneumologists, we realized that only clinical research holds the potential for innovation. Our mission is to carry out clinical trials that provide patients with an opportunity to regain health and contribute to the development of medicine.

article thumbnail

Amarin Reports Third Quarter 2020 Financial Results and Provides Business Update

The Pharma Data

Progressed European regulatory review and commercial preparations : Continued to support regulatory review of VASCEPA by the European Medicines Agency (EMA) with the expectation of an early 2021 approval of VASCEPA for commercial sale in Europe. The design of the REDUCE-IT study was published in March 2017 in Clinical Cardiology.

Sales 40